Category: Money tips Release Date: 2006-10-06
G, on Hong Kong by the end of May at the suspension, the reason was due to a notice on important matters, and this because the market is most likely transmission was simmering the company's overall listing matters. G Unit on the implementation of reform in Hong Kong, the PSA has repeatedly said it would seek an overall listing. Perhaps because of the dim sources in this regard, G on the Hong Kong obvious signs of recent heavy volume pulled up, the stock rose from 10 yuan in 15 yuan, and the day on the resumption of the G will be how the performance of Hong Kong can not help but left us with a trace of look forward to.
Listed as a whole seems to become tradable times, A-share market is another big change. While the other one on the overall listing of news "spread like wildfire," came to the Bridal Tea House inside.
"Shangshiliange would like to take 39 medicines listed as a whole yet." One of the patrons smoke effects of a highly explosive, then immediately in the teahouse has caused a stir, everyone skeptical discussed again.
In the 39 Group, to accelerate the pace of asset reorganization time, there have been on a real group, Fosun Group and Singapore's Temasek and other companies as strategic investors involved in the reorganization of 39, while the present situation, the Group of 39 Shangshiliange White most likely. The market generally believes that potential investors, the real intention is to re-39 39 39 Medicine's core assets.
There is no doubt that medicine is 39 39 Group's core assets, but also the highest quality assets. "Light '999 'the brand valuation of intangible assets on more than 8.3 billion yuan." Lin Mohan, then will be able to prove that 39 Chinese or have a great value.
Group has been very focused on the fact of its development of Chinese medicine, Chinese medicine has become a core industry groups on the solid plate, one now has, including Chia Tai Qingchunbao, Hu Qing-tang, Changzhou Pharmaceutical, Shanghai Sunway Biotech, Guangdong Temple and some other well-known pharmaceutical industry enterprises, including pharmaceutical manufacturers and research institutes nearly 30. Their flag is on a real group Shangshiliange pharmaceutical industry to create an important platform for the real Group's pharmaceutical industry is slowly injected into Shangshiliange, Shangshiliange soon changed its name to the real medicine.
For the pharmaceutical industry to develop a company, the face of 39 such high-quality medical resources, the acquisition is only reasonable that the. The old chapter also expressed his optimistic about mergers and acquisitions, Min Zhao tea said: "It is on the acquisition of 39 real medicine as an excellent opportunity for bigger and stronger. If the successful acquisition of 39, the real Group would face a jump of Shangshiliange of development opportunities. 39 of the pharmaceutical industry and the combined value of the assets will greatly help to improve the pharmaceutical industry on a real plate in the overall strength of Chinese medicine. "
"From the Shangshiliange will be renamed on the actual medical term, integrated pharmaceutical group of resources has become increasingly evident, and to absorb 39, relying on medical resources, listed as a whole, nor is it possible, oh no." In some discussions, tea passenger who think the real acquisition of 39 on both sides of this matter is a development opportunity.
"How to say the Group of 39 also is a company with total assets of more than 20 billion yuan for the country's largest manufacturers of proprietary medicines. It is reported that the real money will be 30 billion injection of 39 packages of medicine, this medicine 39 revive a major help, not to mention 39 of the operational capacity of medicine is restructuring gradually improving. "an acquisition raises a number of patrons on the 39 pharmaceutical market outlook outlook.
Recently, 39 Chinese medicine may be affected by restructuring of the impact of good news, bad trend. The restructuring of the Group of 39 on the real group, the overall pharmaceutical market Shangshiliange backdoor 39 of the expected 000,999 39 can continue to stimulate the recovery of medical, let's wait and see.
